帕金森病相关蛋白可能破坏大脑的废物处理系统
Parkinson's-linked protein may sabotage the brain's waste disposal system
研究发现帕金森病患者脑脊液和硬脑膜中积聚的α-突触核蛋白不仅在大脑内部,还在脑边界组织中积聚,干扰了大脑的废物清除系统。实验显示,这种蛋白的积聚改变了免疫细胞的行为,增加了炎症信号,导致废物清除系统失衡。这为理解帕金森病的病理机制提供了新见解。
A protein's shape can make all the difference between keeping the body running smoothly and contributing to disease. A protein called α-synuclein (α-syn), under normal conditions, helps neurons release neurotransmitters by interacting with tiny structures called synaptic vesicles at the ends of nerve cells. The accumulation of misfolded versions of the same protein can lead to Parkinson's disease, a nervous system disorder that affects movement and gets worse over time. The clumped-up protein also collects in the cerebrospinal fluid (CSF) surrounding the brain and in the brain's outer border tissue, known as the dura mater.
A recent study published in the Journal of Experimental Medicine explores how the buildup of α-syn at the brain's borders impairs central nervous system functions such as waste clearance.
To investigate this, researchers examined donated CSF and dura mater from people with Parkinson's disease and healthy controls, looking for forms of α-syn prone to clumping. They also developed mouse models to study what happens when the brain's waste-clearance system fails.
They saw that the toxic aggregates accumulated not only inside the brain, CSF and dura mater but also immediately adjacent to the meningeal lymphatic vessels, which are responsible for draining fluid and waste out of the skull. In the mouse models, the misfolded protein buildup in these layers altered the behavior of immune cells and threw the brain's waste-clearance system off balance.
Trouble around the borders
For a very long time, the world was unaware of a way to diagnose or detect Parkinson's other than through symptoms. So when α-syn buildup came into the picture as a blood- and CSF-based biomarker, the primary focus was on how the protein builds up inside brain cells.
Even though scientists already knew that clumped α-syn accumulates in the CSF surrounding the brain, it remained unclear how these protein clumps interact with the tissues around the brain and whether they interfere with vital regulatory functions, such as the brain's waste drainage system.
A broader understanding of this process is essential because most experimental therapies focus on clearing toxic proteins directly from the brain tissue. However, if the brain's outer drainage vessels are structurally damaged and inflamed, the cleared waste may have no way out of the skull. This could lead to toxic proteins accumulating again, seeding the next cycle.
To piece together how α-syn disrupts the central nervous system, the researchers examined the problem at several levels. They first looked at postmortem human brain tissue from donors with and without Parkinson's. They then injected glowing, tagged α-syn clumps into the CSF of animals and followed where they went. They also treated human cells grown in the lab with these clumps or with TNF, an inflammation signal. They also carried out RNA analysis to identify a genetic component involved.
Brain's blocked drain
The researchers found clumps of synuclein in the dura mater in tissue donated by people with Parkinson's disease but not in the small group of healthy controls. In mice, both brief and prolonged exposure to synuclein in the CSF disrupted waste flow to lymph nodes in the neck.
The exposure also shifted the immune cell population in the dura, increasing the proportion of macrophages, which engulf waste. With prolonged exposure, levels of the inflammatory TNF signal began to rise in the CSF. Experiments with human lymphatic cells grown in the lab also revealed a similar disruption, in which the clumps weakened connections between neighboring cells and slowed the growth of new vessels.
Genetic data exposed the mechanism for disruption that starts with synuclein signaling border macrophages to activate the Tnf gene, which then upregulates TNF protein, driving vessel breakdown and failure of waste clearance.
The results show how α-syn affects the tissues along the brain's borders and point to meningeal immune activity as another factor behind impaired waste clearance in Parkinson's disease. Further studies are needed to determine whether this could lead to a vicious cycle in which toxic protein buildup impairs drainage and poor drainage triggers further protein buildup.
Written for you by our author Sanjukta Mondal, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You'll get an ad-free account as a thank-you.
Publication details
Taylor J. Stevenson et al., Cerebrospinal fluid and dural accumulation of α-synuclein impairs CNS clearance in Parkinson's disease, Journal of Experimental Medicine (2026). DOI: 10.1084/jem.20251245
Journal information: Journal of Experimental Medicine
Clinical categories
Who's behind this story?
Sanjukta Mondal
Master's in Chemistry. Freelance science journalist and communicator. Published in Chemistry World, BioSpace, and The Hindu. Full profile →
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
© 2026 Science X Network
Citation: Parkinson's-linked protein may sabotage the brain's waste disposal system (2026, November 11) retrieved 11 November 2026 from https://medicalxpress.com/news/2026-11-parkinson-linked-protein-sabotage-brain.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com